GRC 65327

N/A

Report date: 2024/11/11 10:59:25
NMEFirst In Class

Base Information

Drug NameGRC 65327
Drug Alias NameGRC 65327GRC-65327
ClassificationSmall molecules
Mechanisms of ActionE3 ubiquitin-protein ligase CBL-B inhibitors
TargetsE3 ubiquitin-protein ligase CBL-B
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIchnos Glenmark Innovation Inc
China Registration ClassN/A

Develop Information

Active CompaniesIchnos Glenmark Innovation Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A